You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

新華製藥(000756.SZ)：不超3709.2萬股定增計劃獲批

格隆匯 03-23 17:24

格隆匯3月23日丨新華製藥(000756.SZ)公佈，公司於今日收到中國證監會出具的《關於覈準山東新華製藥股份有限公司非公開發行股票的批覆》(證監許可[2022]564號)。中國證監會覈準公司非公開發行不超過3709.1988萬股新股；該批覆自核準發行之日起12個月內有效。

山东新华制药股份(00719.HK)
20240617山东新华制药股份00719
Relevant Stocks
山东新华制药股份(00719.HK)
Relevant Recommendation
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.